At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Account Executive, P&OCS - Value, Access & Payment, Oncology
THIS IS A NATIONAL ACCOUNT EXECUTIVE POSITION AND THEREFORE, THERE IS NO GEOGRAPHIC REQUIREMENT FOR RESIDENCY. HOWEVER, ACCOUNTS ARE PRIMARILY GROUPED GEOGRAPHICALLY. THIS POSITION IS IN THE ROCKY MOUNTAINS WITH ACCOUNTS IN CO, UT, NV, and NM.
The position is responsible for leading the matrix team in account planning and implementation, driving optimal access, and appropriate utilization for the BMS hematology/oncology portfolio across all assigned accounts. These include the largest oncology networks, community practices, oncology cancer centers, pathway companies, state oncology societies, and other oncology/hematology organized customers. Deep knowledge and understanding of the clinical, economic and business model dynamics driving decision making and coverage is critical. Deep understanding of the business of oncology and the clinical label and data for the BMS and competitive portfolio is essential.
The Hematology/Oncology NAE is responsible for developing strong access and business relationships and communicating approved clinical and economic data with key hematology/oncology decision makers and advisors. The Hematology/Oncology NAE develops and ensures execution of the integrated account business plans. He/she is responsible for aligning the full matrix team (VAP, Medical, HEOR, Sales and others across Oncology and Hematology) to develop and execute the plan. The position serves as the primary interface between BMS/VAP and our national hematology/oncology customers. Knowledge and understanding of hematology/oncology access influencers is also important. This includes groups like ASCO, ACCC, COA, NCCN, State Oncology Societies, etc. The position reports to Kim Seibel, Director of Payer and Organized Customer Sales, Hematology/Oncology National Accounts.
Responsibilities:
* Proactively manage access through engagement with key stakeholders, including access influencers, to ensure product access; anticipate and mitigate potential challenges
* Lead matrix collaboration and planning to ensure development of an aligned strategic account plan and coordinated customer interactions across the portfolio
* Drive commercial success within accounts through close matrix collaboration leveraging full BMS capabilities and resources to effectively pull-through account plan from the top-down
* Deliver branded and unbranded access, value, economic, and quality messages and tools
* Establish direct relationships with C-Suite, E-Suite, Medical Directors and key decision makers within assigned customers
* Support appropriate utilization through clinical management programs and tools
* Coordinate matrix team resources and facilitate senior executive interactions as appropriate
* Operate in full compliance to all applicable laws and comply with BMS policies and procedures
Candidate Specifications:
* Bachelors degree
* Oncology and/or Hematology Sales Leadership, Market Access, and/or Marketing/Home Office experience (7+ years)
* Region/National Account management skills/experience (3+ years)
* Oncology, Hematology, Biologics, Specialty and Physician Administered drug expertise
* Track record of success in access/sales/marketing
* Proven leadership skills and ability to network across complex internal and external environment and lead teams without authority
* Possess executive presence and the ability to interact and negotiate with senior account leadership
* Demonstrated ability to develop customer centric approaches, leverage multi-disciplinary capabilities and resources in order to realize objectives
* Demonstrated analytical, negotiation, written and oral communication skills
* Overnight travel, approximately 50%
Preferred Qualifications:
* Advanced degree preferred (MBA, PharmD, RN, etc.)
* Hematology/oncology market access experience preferred
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.